Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant MS4A1 (Rituximab Biosimilar) antibody

Reactivity: Human FACS, ELISA, BLI, Func, SPR Host: Human Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7581287
  • Target See all MS4A1 (Rituximab Biosimilar) products
    MS4A1 (Rituximab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    • 6
    • 2
    • 2
    Human
    Host
    • 3
    • 1
    • 1
    • 1
    Human
    Expression System
    CHO Cells
    Clonality
    • 3
    • 3
    Monoclonal
    Conjugate
    • 6
    This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
    Application
    Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
    Purpose
    Anti-CD20 / MS4A1 Reference Antibody (rituximab)
    Sequence
    QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYNMHWVKQT PGRGLEWIGA IYPGNGDTSY NQKFKGKATL TADKSSSTAY MQLSSLTSED SAVYYCARST YYGGDWYFNV WGAGTTVTVS AASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKAE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K,QIVLSQSPAI LSASPGEKVT MTCRASSSVS YIHWFQQKPG SSPKPWIYAT SNLASGVPVR FSGSGSGTSY SLTISRVEAE DAATYYCQQW TSNPPTFGGG TKLEIKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
    Characteristics
    Anti-CD20 Reference Antibody (rituximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.32 kDa.
    Purity
    >95 %
    Isotype
    IgG1
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Therapeutic Agents by Target and Mechanism: CD20 inhibitors(B lymphocyte antigen CD20 inhibitors), ADCC(antibody-dependent cytotoxicity), CD20(targeted cytolysis)

    Conditions: Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma Rheumatoid Arthritis (Anti-TNF Refractory) Vasculitis ANCA-associated

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    1 mg/mL
    Buffer
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    Storage
    4 °C,-80 °C
    Storage Comment
    +4°C,-80°C
  • Target
    MS4A1 (Rituximab Biosimilar)
    Alternative Name
    CD20 (Rituximab Biosimilar) (MS4A1 (Rituximab Biosimilar) Products)
    Target Type
    Biosimilar
    Background
    Synonyms: Membrane-spanning 4-domains, subfamily A, member 1, MS4A1, B lymphocyte surface antigen B1, Leu-16, Bp35
    Molecular Weight
    146.32 kDa
    UniProt
    P11836
You are here:
Support